108 related articles for article (PubMed ID: 11338912)
1. Postmarketing surveillance of medications and pregnancy outcomes: clarithromycin and birth malformations.
Drinkard CR; Shatin D; Clouse J
Pharmacoepidemiol Drug Saf; 2000 Dec; 9(7):549-56. PubMed ID: 11338912
[TBL] [Abstract][Full Text] [Related]
2. Pregnancy outcome of women inadvertently exposed to ribostamycin during early pregnancy: a prospective cohort study.
Lee SW; Han JY; Choi JS; Chung JH; Kim MY; Yang JH; Koong MK; Nava-Ocampo AA; Koren G
Reprod Toxicol; 2009 Apr; 27(2):196-8. PubMed ID: 19162171
[TBL] [Abstract][Full Text] [Related]
3. A prospective controlled multicentre study of clarithromycin in pregnancy.
Einarson A; Phillips E; Mawji F; D'Alimonte D; Schick B; Addis A; Mastroiacova P; Mazzone T; Matsui D; Koren G
Am J Perinatol; 1998; 15(9):523-5. PubMed ID: 9890248
[TBL] [Abstract][Full Text] [Related]
4. Major congenital malformations after first-trimester exposure to ACE inhibitors.
Cooper WO; Hernandez-Diaz S; Arbogast PG; Dudley JA; Dyer S; Gideon PS; Hall K; Ray WA
N Engl J Med; 2006 Jun; 354(23):2443-51. PubMed ID: 16760444
[TBL] [Abstract][Full Text] [Related]
5. Pregnancy outcome after gestational exposure to the new macrolides: a prospective multi-center observational study.
Bar-Oz B; Diav-Citrin O; Shechtman S; Tellem R; Arnon J; Francetic I; Berkovitch M; Ornoy A
Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):31-4. PubMed ID: 18760873
[TBL] [Abstract][Full Text] [Related]
6. Pregnancy outcome after gestational exposure to metronidazole: a prospective controlled cohort study.
Diav-Citrin O; Shechtman S; Gotteiner T; Arnon J; Ornoy A
Teratology; 2001 May; 63(5):186-92. PubMed ID: 11320529
[TBL] [Abstract][Full Text] [Related]
7. Outcomes of congenital diaphragmatic hernia: a population-based study in Western Australia.
Colvin J; Bower C; Dickinson JE; Sokol J
Pediatrics; 2005 Sep; 116(3):e356-63. PubMed ID: 16140678
[TBL] [Abstract][Full Text] [Related]
8. Clonazepam use in pregnancy and the risk of malformations.
Lin AE; Peller AJ; Westgate MN; Houde K; Franz A; Holmes LB
Birth Defects Res A Clin Mol Teratol; 2004 Aug; 70(8):534-6. PubMed ID: 15329832
[TBL] [Abstract][Full Text] [Related]
9. Outcomes of infants born to mothers with inflammatory bowel disease: a population-based cohort study.
Dominitz JA; Young JC; Boyko EJ
Am J Gastroenterol; 2002 Mar; 97(3):641-8. PubMed ID: 11926208
[TBL] [Abstract][Full Text] [Related]
10. Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003-2004.
O'Leary DR; Kuhn S; Kniss KL; Hinckley AF; Rasmussen SA; Pape WJ; Kightlinger LK; Beecham BD; Miller TK; Neitzel DF; Michaels SR; Campbell GL; Lanciotti RS; Hayes EB
Pediatrics; 2006 Mar; 117(3):e537-45. PubMed ID: 16510632
[TBL] [Abstract][Full Text] [Related]
11. Pregnancy outcome following first-trimester exposure to zopiclone: a prospective controlled cohort study.
Diav-Citrin O; Okotore B; Lucarelli K; Koren G
Am J Perinatol; 1999; 16(4):157-60. PubMed ID: 10458526
[TBL] [Abstract][Full Text] [Related]
12. Clinical implications of increased congenital malformations after first trimester exposures to angiotensin-converting enzyme inhibitors.
Cooper WO
J Cardiovasc Nurs; 2008; 23(1):20-4. PubMed ID: 18158502
[TBL] [Abstract][Full Text] [Related]
13. Use of benzodiazepines and benzodiazepine receptor agonists during pregnancy: neonatal outcome and congenital malformations.
Wikner BN; Stiller CO; Bergman U; Asker C; Källén B
Pharmacoepidemiol Drug Saf; 2007 Nov; 16(11):1203-10. PubMed ID: 17894421
[TBL] [Abstract][Full Text] [Related]
14. Early pregnancy azathioprine use and pregnancy outcomes.
Cleary BJ; Källén B
Birth Defects Res A Clin Mol Teratol; 2009 Jul; 85(7):647-54. PubMed ID: 19343728
[TBL] [Abstract][Full Text] [Related]
15. Bupropion in pregnancy and the prevalence of congenital malformations.
Cole JA; Modell JG; Haight BR; Cosmatos IS; Stoler JM; Walker AM
Pharmacoepidemiol Drug Saf; 2007 May; 16(5):474-84. PubMed ID: 16897811
[TBL] [Abstract][Full Text] [Related]
16. Maternal use of fluconazole and risk of congenital malformations: a Danish population-based cohort study.
Nørgaard M; Pedersen L; Gislum M; Erichsen R; Søgaard KK; Schønheyder HC; Sørensen HT
J Antimicrob Chemother; 2008 Jul; 62(1):172-6. PubMed ID: 18400803
[TBL] [Abstract][Full Text] [Related]
17. A review of pregnancy outcomes after exposure to orally inhaled or intranasal budesonide.
Gluck PA; Gluck JC
Curr Med Res Opin; 2005 Jul; 21(7):1075-84. PubMed ID: 16004676
[TBL] [Abstract][Full Text] [Related]
18. Surveillance study of Sinupret in comparison with data of the Mainz birth registry.
Ismail C; Wiesel A; März RW; Queisser-Luft A
Arch Gynecol Obstet; 2003 Feb; 267(4):196-201. PubMed ID: 12592417
[TBL] [Abstract][Full Text] [Related]
19. Maternal periconceptional illicit drug use and the risk of congenital malformations.
van Gelder MM; Reefhuis J; Caton AR; Werler MM; Druschel CM; Roeleveld N;
Epidemiology; 2009 Jan; 20(1):60-6. PubMed ID: 19057385
[TBL] [Abstract][Full Text] [Related]
20. Surveillance of adverse fetal effects of medications (SAFE-Med): findings from the international Clearinghouse of birth defects surveillance and research.
Lisi A; Botto LD; Robert-Gnansia E; Castilla EE; Bakker MK; Bianca S; Cocchi G; de Vigan C; Dutra Mda G; Horacek J; Merlob P; Pierini A; Scarano G; Sipek A; Yamanaka M; Mastroiacovo P
Reprod Toxicol; 2010 Jul; 29(4):433-42. PubMed ID: 20347959
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
